杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/19 | 1,620 | 1,628 | 1,608 | 1,613 | -17 | -1% | 48,100 |
| 2024/08/16 | 1,625 | 1,632 | 1,608 | 1,630 | +25 | +1.6% | 57,500 |
| 2024/08/15 | 1,618 | 1,618 | 1,601 | 1,605 | -5 | -0.3% | 46,700 |
| 2024/08/14 | 1,606 | 1,612 | 1,594 | 1,610 | +4 | +0.2% | 67,200 |
| 2024/08/13 | 1,597 | 1,612 | 1,597 | 1,606 | +9 | +0.6% | 53,300 |
| 2024/08/09 | 1,611 | 1,617 | 1,571 | 1,597 | +23 | +1.5% | 94,000 |
| 2024/08/08 | 1,551 | 1,606 | 1,551 | 1,574 | +1 | +0.1% | 82,300 |
| 2024/08/07 | 1,551 | 1,611 | 1,543 | 1,573 | +11 | +0.7% | 155,600 |
| 2024/08/06 | 1,552 | 1,593 | 1,530 | 1,562 | +63 | +4.2% | 160,000 |
| 2024/08/05 | 1,634 | 1,634 | 1,499 | 1,499 | -157 | -9.5% | 211,300 |
| 2024/08/02 | 1,686 | 1,686 | 1,648 | 1,656 | -30 | -1.8% | 163,400 |
| 2024/08/01 | 1,703 | 1,751 | 1,678 | 1,686 | -35 | -2% | 186,900 |
| 2024/07/31 | 1,694 | 1,726 | 1,694 | 1,721 | +13 | +0.8% | 91,800 |
| 2024/07/30 | 1,714 | 1,718 | 1,703 | 1,708 | -9 | -0.5% | 84,900 |
| 2024/07/29 | 1,711 | 1,719 | 1,706 | 1,717 | +16 | +0.9% | 76,200 |
| 2024/07/26 | 1,701 | 1,710 | 1,696 | 1,701 | -6 | -0.4% | 80,000 |
| 2024/07/25 | 1,707 | 1,715 | 1,699 | 1,707 | -4 | -0.2% | 151,800 |
| 2024/07/24 | 1,714 | 1,721 | 1,705 | 1,711 | -10 | -0.6% | 92,100 |
| 2024/07/23 | 1,705 | 1,721 | 1,705 | 1,721 | +16 | +0.9% | 74,500 |
| 2024/07/22 | 1,726 | 1,731 | 1,705 | 1,705 | -24 | -1.4% | 98,000 |
| 2024/07/19 | 1,721 | 1,729 | 1,709 | 1,729 | ±0 | ±0% | 83,300 |
| 2024/07/18 | 1,710 | 1,734 | 1,710 | 1,729 | +10 | +0.6% | 84,700 |
| 2024/07/17 | 1,715 | 1,719 | 1,705 | 1,719 | +14 | +0.8% | 61,900 |
| 2024/07/16 | 1,716 | 1,723 | 1,705 | 1,705 | -23 | -1.3% | 86,300 |
| 2024/07/12 | 1,707 | 1,728 | 1,707 | 1,728 | +14 | +0.8% | 103,900 |
| 2024/07/11 | 1,704 | 1,718 | 1,704 | 1,714 | +14 | +0.8% | 99,500 |
| 2024/07/10 | 1,700 | 1,702 | 1,688 | 1,700 | ±0 | ±0% | 79,500 |
| 2024/07/09 | 1,688 | 1,706 | 1,685 | 1,700 | +17 | +1% | 113,500 |
| 2024/07/08 | 1,699 | 1,702 | 1,677 | 1,683 | ±0 | ±0% | 157,200 |
| 2024/07/05 | 1,695 | 1,698 | 1,678 | 1,683 | -17 | -1% | 90,900 |
| 2024/07/04 | 1,695 | 1,700 | 1,694 | 1,700 | +9 | +0.5% | 62,900 |
| 2024/07/03 | 1,691 | 1,699 | 1,688 | 1,691 | -3 | -0.2% | 69,300 |
| 2024/07/02 | 1,698 | 1,704 | 1,691 | 1,694 | -3 | -0.2% | 77,900 |
| 2024/07/01 | 1,706 | 1,706 | 1,692 | 1,697 | -5 | -0.3% | 92,500 |
| 2024/06/28 | 1,704 | 1,706 | 1,692 | 1,702 | ±0 | ±0% | 70,800 |
| 2024/06/27 | 1,710 | 1,710 | 1,695 | 1,702 | -12 | -0.7% | 75,500 |
| 2024/06/26 | 1,705 | 1,717 | 1,697 | 1,714 | +8 | +0.5% | 93,600 |
| 2024/06/25 | 1,722 | 1,722 | 1,703 | 1,706 | -11 | -0.6% | 204,700 |
| 2024/06/24 | 1,715 | 1,720 | 1,704 | 1,717 | +20 | +1.2% | 91,300 |
| 2024/06/21 | 1,703 | 1,718 | 1,693 | 1,697 | -12 | -0.7% | 208,800 |
| 2024/06/20 | 1,693 | 1,713 | 1,693 | 1,709 | +9 | +0.5% | 91,300 |
| 2024/06/19 | 1,697 | 1,701 | 1,686 | 1,700 | +9 | +0.5% | 71,300 |
| 2024/06/18 | 1,676 | 1,694 | 1,676 | 1,691 | -4 | -0.2% | 61,100 |
| 2024/06/17 | 1,685 | 1,695 | 1,674 | 1,695 | +12 | +0.7% | 72,500 |
| 2024/06/14 | 1,690 | 1,698 | 1,680 | 1,683 | +2 | +0.1% | 89,200 |
| 2024/06/13 | 1,685 | 1,687 | 1,675 | 1,681 | -11 | -0.7% | 47,700 |
| 2024/06/12 | 1,699 | 1,705 | 1,688 | 1,692 | -2 | -0.1% | 67,400 |
| 2024/06/11 | 1,687 | 1,699 | 1,683 | 1,694 | +4 | +0.2% | 64,900 |
| 2024/06/10 | 1,669 | 1,693 | 1,664 | 1,690 | +33 | +2% | 87,800 |
| 2024/06/07 | 1,655 | 1,662 | 1,646 | 1,657 | +3 | +0.2% | 109,000 |
151～
200
件表示中 / 3671件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 145,400円 | +3.2% | +4.5% | 3.58% | 16.71倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.60倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 192,800円 | +21.7% | +999.9% | 0.00% | 8.03倍 | 2.66倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 栄研化 | 220,400円 | +0.4% | -8.4% | 2.40% | 28.30倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 85,200円 | +22.8% | - | 0.00% | 69.61倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
